Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
3.090
-0.290 (-8.58%)
At close: Jun 3, 2026, 4:00 PM EDT
3.110
+0.020 (0.64%)
After-hours: Jun 3, 2026, 7:14 PM EDT
Cellectis Employees
As of December 31, 2025, Cellectis had 229 total employees, including 224 full-time and 5 part-time employees. The number of employees increased by 7 or 3.15% compared to the previous year.
Employees
229
Change (1Y)
7
Growth (1Y)
3.15%
Revenue / Employee
$328,000
Profits / Employee
-$293,581
Market Cap
227.37M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 229 | 7 | 3.15% | 224 | 5 |
| Dec 31, 2024 | 222 | 1 | 0.45% | 216 | 6 |
| Dec 31, 2023 | 221 | -16 | -6.75% | 216 | 5 |
| Dec 31, 2022 | 237 | -63 | -21.00% | 231 | 6 |
| Dec 31, 2021 | 300 | 19 | 6.76% | 294 | 6 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Entrada Therapeutics | 152 |
| Codexis | 146 |
| Coherus Oncology | 145 |
| Adagene | 128 |
| AC Immune | 122 |
| SAB Biotherapeutics | 86 |
| Protara Therapeutics | 46 |
CLLS News
- 6 days ago - Cellectis initiated with an Overweight at Barclays - TheFly
- 13 days ago - Cellectis Slides: Corporate presentation - Filings
- 14 days ago - Cellectis' Annual Shareholders General Meeting to be Held on June 25, 2026 - GlobeNewsWire
- 22 days ago - Cellectis (CLLS) Announces Clinical Trial Presentations at EHA Congress - GuruFocus
- 22 days ago - Cellectis to present clinical data on lasme-cel, eti-cel at EHA Congress - TheFly
- 22 days ago - Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress - GlobeNewsWire
- 23 days ago - Cellectis (CLLS) Reports Strong Cash Position for Future Operations - GuruFocus
- 23 days ago - Cellectis (CLLS) Reports Q1 Revenue and Highlights Future Developments - GuruFocus